No takes yet. Share an insight, caveat, or question.
Retrospective cohort study finds poor survival post-progression after bispecific antibody therapy in r/r large B-cell lymphoma.
Mian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: